Literature DB >> 3470548

Interactions of natural effector cells and prostaglandins in the control of metastasis.

A M Fulton.   

Abstract

The roles of prostaglandins and nonspecific immune effector cells were examined in the growth and metastasis of a series of murine mammary adenocarcinomas growing in BALB/c mice. The spontaneous metastasis of the highly metastatic tumor designated 410.4 was inhibited by oral administration of the prostaglandin synthesis inhibitor indomethacin (INDO), whereas treatment of mice with the interferon inducer polyinosinic-polycytidylic acid (poly I:C) delayed tumor growth but did not affect the rate of spontaneous metastasis. Lung colony formation was dramatically reduced by poly I:C treatment following iv tumor cell inoculation (experimental metastasis), whereas oral INDO had no significant effect. Suppression of natural killer cell activity with anti-asialo GM1 (asGM1) antibody increased lung colony-forming ability of mammary tumor lines with either high, moderate, or low metastatic capacity. Although pretreatment of the recipient with INDO did not alter the incidence of experimental metastasis, culture of the tumor cells with INDO (1 micron) prior to iv inoculation inhibited the appearance of lung colonies by greater than 90%. This beneficial effect was dependent on an asGM1-positive population. These results suggest that in this murine mammary tumor system, prostaglandin synthesis contributes to metastatic capacity and that the beneficial effects of INDO may be attributable, in part, to the enhancement of tumor cell sensitivity to natural cytotoxic effector mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470548

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Inhibition of lung colonization at two different steps in the metastatic sequence.

Authors:  C J Aslakson; D McEachern; D H Conaway; F R Miller
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Stress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferation.

Authors:  Orly Ordan; Ronit Rotem; Ilona Jaspers; Eliezer Flescher
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.

Authors:  N K Khoo; F P Chan; M N Saarloos; P K Lala
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

4.  Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression.

Authors:  T Reissmann; P Hilgard; R Voegeli; J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

Review 6.  Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?

Authors:  Zhongxing Liao; Kathryn A Mason; Luka Milas
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family.

Authors:  Natalia Goldin; Alina Heyfets; Dorit Reischer; Eliezer Flescher
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

8.  MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.

Authors:  F Esteban; M Redondo; M Delgado; F Garrido; F Ruiz-Cabello
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.